Follow
Nicholas S. Moore
Nicholas S. Moore
Verified email at yale.edu
Title
Cited by
Cited by
Year
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
AH Nassar, S Abou Alaiwi, SH AlDubayan, N Moore, KW Mouw, ...
Genetics in Medicine 22 (4), 709-718, 2020
562020
Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma
SH AlDubayan, JR Conway, SY Camp, L Witkowski, E Kofman, ...
Jama 324 (19), 1957-1969, 2020
372020
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections
H Chung, C Merakou, MM Schaefers, KB Flett, S Martini, R Lu, ...
Nature Communications 13 (1), 1231, 2022
232022
The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in …
F Wang, H Liu, X Shen, H Ao, N Moore, L Gao, L Chen, H Hu, H Ma, ...
Neurobiology of Aging 36 (1), 111-122, 2015
232015
Integrating molecular profiles into clinical frameworks through the molecular oncology almanac to prospectively guide precision oncology
B Reardon, ND Moore, NS Moore, E Kofman, SH AlDubayan, ...
Nature cancer 2 (10), 1102-1112, 2021
172021
Bladder cancer radiation oncology of the future: prognostic modelling, radiomics, and treatment planning with artificial intelligence
NS Moore, A McWilliam, S Aneja
Seminars in Radiation Oncology 33 (1), 70-75, 2023
72023
Inherited DNA repair and cell cycle gene defects in chronic lymphocytic leukemia.
NS Moore, SH Aldubayan, A Taylor-Weiner, S Stilgenbauer, G Getz, ...
Journal of Clinical Oncology 37 (15_suppl), 1508, 2019
32019
Comparison of Pulmonary Toxicity after Total Body Irradiation-and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric …
KX Liu, N Poux, KY Shin, N Moore, YH Chen, S Margossian, JS Whangbo, ...
Transplantation and Cellular Therapy 28 (8), 502. e1-502. e12, 2022
22022
Inherited DNA repair and cell cycle gene defects in chronic lymphocytic leukemia
BJR Moore NS, AlDubayan SH, Taylor-Weiner A, Stilgenbauer S, Getz G., Wu CJ ...
HemaSphere 3, 512-513, 2019
2*2019
Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma
SH Han, SY Camp, H Chu, R Collins, R Gillani, J Park, Z Bakouny, ...
European Urology Open Science 62, 107-122, 2024
12024
Clinical interpretation of integrative molecular profiles to guide precision cancer medicine
B Reardon, ND Moore, N Moore, E Kofman, S Aldubayan, A Cheung, ...
bioRxiv, 2020.09. 22.308833, 2020
12020
Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy
N Verma, JH Laird, NS Moore, TJ Hayman, N Housri, GW Peters, ...
Advances in Radiation Oncology 9 (6), 101500, 2024
2024
Abstract P01: Impact of Germline and Somatic ATM Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition
K Mashima, N Moore, M Mikhaleva, A Petráčková, S Shupe, ...
Blood Cancer Discovery 5 (2_Supplement), P01-P01, 2024
2024
Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL)
K Mashima, BL Lampson, A Gupta, N Moore, A Petrackova, SJ Shupe, ...
Blood 140 (Supplement 1), 9853-9854, 2022
2022
Predictors of Early Polymetastasis after Comprehensive Local Therapy for Synchronous Oligometastatic NSCLC
JH Laird Jr, N Verma, NS Moore, HSM Park, S Aneja
International Journal of Radiation Oncology, Biology, Physics 114 (3), S32, 2022
2022
Radioresistant Lung Oligometastases: Impact of Histology and Dose on Local Control
N Verma, JH Laird, NS Moore, HSM Park
International Journal of Radiation Oncology, Biology, Physics 114 (3), e407, 2022
2022
Oligometastatic Tumor Size as a Predictor of Distant Failure in Synchronous Oligometastatic NSCLC
NS Moore, J Laird, N Verma, HSM Park
International Journal of Radiation Oncology, Biology, Physics 114 (3), e406, 2022
2022
PULMONARY TOXICITY AFTER TOTAL BODY IRRADIATION-BASED AND BUSULFAN-BASED MYELOABLATIVE CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC AND …
KX Liu, N Poux, N Moore, S Margossian, JS Whangbo, CN Duncan, ...
PEDIATRIC BLOOD & CANCER 68, S189-S190, 2021
2021
Prioritizing Germline and Somatic Variants for Precision Oncology
NS Moore
Harvard University, 2020
2020
A molecular oncology almanac for integrative clinical interpretation of molecular profiles to guide precision cancer medicine
B Reardon, NS Moore, ND Moore, E Kofman, E Van Allen
Cancer Research 79 (13 supplement), 2470-2470, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20